inactivated virus vaccine coronavac (Sinovac BioTech)
90
Structured Review
Sinovac BioTech
inactivated virus vaccine coronavac
Inactivated Virus Vaccine Coronavac, supplied by Sinovac BioTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inactivated+vaccine+coronavac/inactivated+vaccine+coronavac/pmc12255310-56-9-13
Average 90 stars, based on 1 article reviews
Inactivated Virus Vaccine Coronavac, supplied by Sinovac BioTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inactivated+vaccine+coronavac/inactivated+vaccine+coronavac/pmc12255310-56-9-13
Average 90 stars, based on 1 article reviews
inactivated virus vaccine coronavac - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Plasmid Preparation:Article Title: Anti–severe acute respiratory syndrome coronavirus 2 spike receptor-binding domain antibody levels in patients with systemic lupus erythematosus based on vaccination status and related factors in Indonesia Article Snippet: We used total sampling, wherein all patients who met the Article Title: COVID-19 related acute necrotizing encephalopathy and acute myocarditis in an adult female: a novel case report of brain injury and myocarditis Article Snippet: She had been vaccinated three times of inactivated Article Title: Comparative Effectiveness and Safety of BNT162b2 and CoronaVac in Hong Kong: A Target Trial Emulation. Article Snippet: Please cite this article as: Eric Yuk Fai Wan , Boyuan Wang , Amanda Lauren Lee , Jiayi Zhou , Celine Sze Ling Chui , Francisco Tsz Tsun Lai , Xue Li , Carlos King Ho Wong , Ivan Fan Ngai Hung , Chak Sing Lau , Esther Wai Yin Chan , Ian Chi Kei Wong , Comparative Effectiveness and Safety of BNT162b2 and CoronaVac in Hong Kong: A Target Trial Emulation, International Journal of Infectious Diseases (2024), doi: https://doi.org/10.1016/j.ijid.2024.107149 Article Title: Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac. Article Snippet: Corona virus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has affected the whole world.. Acquired thrombotic thrombocytopenic purpura (TTP) has been reported after administration of mRNA or adenoviral vector-based COVID-19 vaccines, including Ad26.COV2-S, BNT162b2, mRNA-1273, and ChAdOx1 nCov-19.. However, whether inactivated vaccines, such as CoronaVac, could cause TTP and whether the symptoms in TTPs caused by inactivated vaccines are different from previously reported cases are unknown. Article Title: An inactivated SARS-CoV-2 vaccine based on a Vero cell culture-adapted high-titer virus confers cross-protection in small animals Article Snippet: Nevertheless, reported data suggests that I-P60 induces similar levels of homologous neutralizing titers in BALB/c mice as the Article Title: An inactivated SARS-CoV-2 vaccine based on a Vero cell culture-adapted high-titer virus confers cross-protection in small animals Article Snippet: Inactivated vaccines developed by Article Title: An inactivated SARS-CoV-2 vaccine based on a Vero cell culture-adapted high-titer virus confers cross-protection in small animals. Article Snippet: Inactivated vaccines developed by |